Search - tctmd.com

Displaying 81 - 100 of 116

Sort: Relevancy | Date

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Conference News ESC 2016

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

Todd Neale

August 27, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Shelley Wood

July 27, 2016

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Industry News

Sequent Medical Announces Completion of Patient Enrollment in IDE Study for the WEB Aneurysm Embolization System

March 07, 2016

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Conference News ISC 2016

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Todd Neale

February 16, 2016

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

MRI May Help Predict Which Stroke Patients Benefit Most From Endovascular Therapy

L.A. McKeown

November 19, 2015

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Industry News

Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients

July 28, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

Meta-analysis Supports Endovascular Therapy for Acute Stroke

Nicole Lou

June 23, 2015

News Daily News

More Data Support Mechanical Thrombectomy in Acute Stroke Treatment

L.A. McKeown

April 29, 2015

News Daily News

IMS III: Adding Endovascular Therapy to IV tPA Boosts Function, QoL After Severe Stroke

L.A. McKeown

April 17, 2015

Advertisement

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Sequent Medical Announces Completion of Patient Enrollment in IDE Study for the WEB Aneurysm Embolization System

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

MRI May Help Predict Which Stroke Patients Benefit Most From Endovascular Therapy

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Meta-analysis Supports Endovascular Therapy for Acute Stroke

More Data Support Mechanical Thrombectomy in Acute Stroke Treatment

IMS III: Adding Endovascular Therapy to IV tPA Boosts Function, QoL After Severe Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content